PANTAVIB INJECTIONPANTOPRAZOLE 40mg. IP

Pantavib Injection is used in adults for GERD with a history of erosive esophagitis and for pathological hypersecretory conditions. Main uses: treatment of gastroesophageal reflux disease (GERD) with a history of erosive esophagitis in adults, for up to 10 days; pathological hypersecretory conditions in adults; zollinger-Ellison (ZE) syndrome in adults.

Common side effects of Pantavib Injection include headache; diarrhoea; nausea; abdominal pain; vomiting; flatulence. Get medical help at once if you notice injection site reactions including thrombophlebitis; acute tubulointerstitial nephritis (kidney inflammation); severe skin reactions.

Pantavib Injection contains Pantoprazole 40 mg. Pantavib Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Pantavib Injection is ₹54.24 for a pack of 1’s. For chemists and distributors, the PTR is ₹41.33 and the PTS is ₹37.19.

Pantavib Injection contains Pantoprazole 40 mg. It comes in a pack of 1’s.

Pantoprazole works at the acid-secreting cells of the stomach lining, where it blocks the acid pump called (H+,K+)-ATPase. By stopping this final step of acid production, it lowers both resting and stimulated stomach acid secretion, and the effect lasts longer than 24 hours. Lower acid levels give the inflamed or damaged lining of the oesophagus and stomach a chance to settle while the underlying condition is managed.

Must not be used in patients with known hypersensitivity to pantoprazole, any component of the formulation, or any substituted benzimidazole. Must not be used in patients receiving rilpivirine-containing products. Check with a doctor first if you have kidney trouble, low magnesium, liver disease, or need long-term therapy.

Pantavib Injection is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.